News & Articles
SEXUAL HARASSMENT ELEARNING FOR EMPLOYEES AND MANAGERS

SEXUAL HARASSMENT ELEARNING FOR EMPLOYEES AND MANAGERS What comes to mind when you think of a constructive work environment? Is…

HOW TO RECOGNIZE AND OVERCOME BIAS

Diversity eLearning Categorization is universal. With so much information and stimuli coming our way, the brain’s instinct is to sort…

Time Management elearning

Time Management Reaching your professional or personal goals isn’t about having more time—it’s about making the most of the time…

Create an enviable team culture an eLearning course

What Is Team Culture and Why Does It Matter? The term “team culture” is a popular buzzword. It’s a selling point for…

A guide to good business ethics

DOING THE RIGHT THING: A GUIDE TO GOOD BUSINESS ETHICS What Are Business Ethics? When talking about business ethics, you’ve…

What is integrity?

The Meaning Behind a Buzzword “Integrity” is an all-too-popular term. We often see companies use it in their brand promises…

Concinto introduces business E-learning courses

Concinto business e-learning Accelerate your team’s skills development with an online learning platform built to maximize learner engagement and long-term…

Concinto and William Paterson University signed an education collaboration agreement.

Concinto and William Paterson University signed an education collaboration agreement. We are pleased to announce that William Paterson University (WPUNJ)…

The use of medical cannabis in older patients

The use of medical cannabis in older patients The use of medical cannabis has increased in recent years due to…

CBD users’ profiles in North America and Europe

CBD users’ profiles in North America and Europe

The future of delivery methods of cannabis-based medications

The analysis of the Concinto clinical trial database Most of the registered clinical trials on cannabinoids have investigated the oral…

The future of clinical research on cannabinoids

Although conducting clinical trials on cannabis and cannabinoids has been challenging for researchers and clinicians, the number of registered clinical…

The Interactive Summary of clinical studies

An interactive summary An interactive summary is a new way of summarizing and presenting complex information. At Concinto, we develop…

Number of medical cannabis patients in the US by States

According to a survey by Ipsos, only 9% of Americans support the ban on the medical use of cannabis. The…

Concinto is now a registered supplier on scientist.com

Concinto becomes a registered supplier on scientist.com, an online marketplace that connects buyers and sellers of research services in the…

MCCEP is now an accredited certificate program for pharmacists.

A competency-mapped accredited certificate program. We are pleased to announce that the Canadian Council on Continuing Education in Pharmacy (CCCEP)…

BCPhA and Concinto sign a collaboration agreement

BCPhA selects Concinto’s accredited programs for its members Concinto recently received accreditation for its continuing education programs from the Canadian…

Introducing Concipio

Introducing Concipio, an interactive online healthcare education platform.

Concinto receives accreditation from CCCEP

Concinto is now an accredited continuing education provider by CCCEP.

Why does Canada still not have a national eHealth system?

The initial national IT efforts in Canada started in the late 1990s. Canada Health Infoway (CHI), an independent not-for-profit organization…

Pharma shall be part of the patient-centered care

The global landscape of delivery of care is changing, and outcome-driven approaches in collaboration with the patient circle of care…

Innovation in the post-COVID world

Covid-19 has irrevocably changed the way businesses will compete over the next decade. Firms that choose to capitalize on these…

Our challenge in using information technologies

“Experts estimate that as many as 98,000 people die in any given year from medical errors that occur in hospitals….

New consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain management

New consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain management An analysis by the United Nations Office…

Can cannabinoids and particularly CBD be an adjunct therapy for Colorectal Adenocarcinoma?

Adenocarcinoma is the most common type of colorectal cancer. The inhibition of the cancer cell proliferation and induction of apoptosis…

Antineoplastic properties of cannabinoids

The potential role of phytocannabinoids and the endocannabinoid system (ECS) in confining malignant tumors is among the most discussed topics…

Does CBD inhibit FAAH?

CBD is proposed to inhibit FAAH, resulting in increased anandamide levels, thereby activating CB1, CB2, and TRPV1 receptors1&2. However, more…

CBD impact on Acute lymphoblastic leukemia (ALL) of T lineage (T-ALL)

Acute lymphoblastic leukemia (ALL) of T lineage (T-ALL) occurs in 15% of childhood and 25% of adult ALL cases. It…

What do we know about CBDA?

CBDA is one of the cannabinoid acids produced in the trichomes of the cannabis plant. CBDA  can easily be decarboxylated…

Does CBN help with insomnia?

CBN or cannabinol is a non-enzymatic oxidative by-product of THC. It has a lower affinity for CB1 and CB2 receptors…

The prevalence of problematic use of prescription opioids and Cannabis-Based Medications (CBMs) among chronic pain patients

The concerns about the problematic use of CBMs are among the most heated debates among healthcare practitioners about integrating CBMs…

Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis – A systematic review

The result of this systematic review indicated that while HCPs (Healthcare Professionals) believed that medical cannabis is a viable, useful…

Cannabis-Based Medications (CBMs) for managing weight loss in patients with advanced cancer

The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study Loss of…

What do we know about CBD dosing for medicinal purposes?

Although CBD is one of the most used cannabinoids for medicinal purposes, the evidence about the dosing of CBD-based products…

The use of Cannabis-based Medications (CBMs) to manage psychological and behavioral issues in patients with dementia

The majority of patients with dementia will develop psychological and behavioral issues such as agitation, delusion, and hallucination during the…

Finnish Food Authority has pulled CBD products from the market

European Union has designated Cannabidiol (CBD) as Novel Food. Novel Foods are not allowed to be placed on the market…

Medical cannabis will be more readily available at a lower cost in the Czech Republic

The Czech Republic Ministry of Health submitted an amendment to the Act on Addictive Substances for interdepartmental comment procedure. The…

The role of the endocannabinoid system in the bone

Bone undergoes continuous destruction and formation. In healthy individuals, the two processes are in fine balance, maintaining a constant, homeostatically…

Concinto adds analytical consulting to its services

We are pleased to announce that we have added cannabinoid analytical consulting and education services to our platform. This service…

Cannabis strains used in research in the US are more similar to hemp.

Cannabis strains used in research in the US are more similar to hemp. Can we generalize the result of clinical…

β-Caryophyllene (BCP) and Neurodegenerative Disorders

Neurodegenerative disorders such as dementia, multiple sclerosis (MS), and Alzheimer’s disease (AD) share neuroinflammatory characterization. CB2 receptor agonists have shown…

CBD and Autism

A recently published observational study on effects of CBD-Enriched cannabis extract on Autism Spectrum Disorders, highlights the need for double-blind…

Trusting your gut on big decisions

Here is an interesting article by Laura Huang on when we need to trust our gut when making big decisions https://hbr.org/2019/10/when-its-ok-to-trust-your-gut-on-a-big-decision

Why Americans use CBD?

A recent Gallup survey indicates that 1 in 7 Americans are using CBD. 40% of users utilize CBD products for…

Atypical cannabinoid targets

Cannabinoids effects on the central and peripheral nervous systems is primarily attributed to two G-protein-coupled receptors, cannabinoid receptors type 1…

Cost-effectiveness of medical cannabis in treating chronic pain

Source:National Report: Apparent Opioid-related Deaths in Canada Published The opiate crisis is a pressing public health issue in Canada and…

A new prospective cohort study presents the effects of CBD on opioid reduction and quality of life of chronic pain patients

Over half of chronic pain patients (53%) that used between 30 to 60 mg CBD extract daily, reduced or eliminated…

Manipulation of the endocannabinoid system could be a promising therapy to control Parkinson’s disease and l-DOPA-induced dyskinesia symptoms

According to a literature review published in the journal of Neurotoxicity Research, cannabinoids, provide a potential multi-targeted treatment strategy for…

Our recent news and articles

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.